Farallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks
In this article, we discuss Farallon Capital: a global and diversified hedge fund and its top stock picks.
Better Therapeutics Inc. (BTTX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 216,165 | $42,152 | +727% | 0% |
| 2. | Millennium Management Israel Englander | 128,749 | $25,106 | +250% | 0% |
| 3. | 3,000 | $585 | -35% | 0% | |
| 4. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.73 | 1,233,045 | 13,030,393 | 2023-07-27 | Filing | ||
| $0.73 | 54,802 | 388,191 | 2023-07-27 | Filing | ||
| $0.73 | 274,010 | 728,368 | 2023-07-27 | Filing | ||
| $0.73 | 34,251 | 35,851 | 2023-07-27 | Filing | ||
| $0.73 | 137,005 | 429,429 | 2023-07-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.00 | 200,000 | Large Shareholder, Officer, Director | 1,374,000 | 2021-04-07 | Filing | |
| $9.00 | 200,000 | Large Shareholder | 1,374,000 | 2021-04-07 | Filing | |
| $9.00 | 200,000 | Large Shareholder, Officer, Director | 1,374,000 | 2021-04-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 356,270 | $65,197 | 0.01% | |
| 2. | 198,154 | $38,640 | 0% | |
| 3. | 168,821 | $32,920 | 0% | |
| 4. | 88,635 | $17,284 | 0% | |
| 5. | 71,000 | $13,845 | 0% |
News See All
Better Therapeutics, Inc. (NASDAQ:BTTX) Q3 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Better Therapeutics' Third Quarter 2023 Business Update Call. At this time all participants are in a listen-only mode.
Better Therapeutics, Inc. (NASDAQ:BTTX) Q2 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by, and welcome to the Better Therapeutics' Second Quarter 2023 Update Call. At this time all participants are in a listen-only mode.
Better Therapeutics, Inc. (NASDAQ:BTTX) Q1 2023 Earnings Call Transcript
Operator: Good morning and thank you for standing by, and welcome to the Better Therapeutics' First Quarter 2023 Conference Call. At this time all participants are in a listen-only mode.
Hedge Fund and Insider Trading News: Paul Marshall, Chris Rokos, D. E. Shaw, Mondrian Investment Partners, AQR Capital Management, Morgan Creek Digital, Diameter Capital Partners, Lovesac Co (LOVE), Better Therapeutics, Inc. (BTTR), and More
U.S. hedge fund heavyweight D. E. Shaw is opening two offices in India, the company said on Tuesday, joining rivals Millennium and AQR Capital Management which are also expanding in the country. D.E.
Hedge Fund and Insider Trading News: Ken Griffin, Warren Buffett, King Street Capital Management, Light Street Capital Management, Better Therapeutics Inc (BTTX), Nogin, Inc. (NOGN), and More
Harvard University wants us to bow down to the exceptional generosity of Kenneth C. Griffin, a hedge fund billionaire who just made a $300-million gift to the school’s graduate program.
Thomas Steyer's Farallon Capital is Buying These 10 Stocks
In this article, we discuss 10 stocks that Thomas Steyer’s Farallon Capital is buying.
Billionaire Hedge Funds
